Navigation Links
RoundTable Healthcare Partners Announces Sale of Vesta Funding, Inc. to The Lubrizol Corporation
Date:8/1/2014

LAKE FOREST, Ill., Aug. 1, 2014 /PRNewswire/ -- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today the sale of Vesta Funding, Inc. ("Vesta") to The Lubrizol Corporation ("Lubrizol"). Lubrizol, a Berkshire Hathaway company, is a specialty chemical company that produces and supplies technologies to customers in the global transportation, industrial and consumer markets. Terms of the transaction were not disclosed.

Vesta is an ISO-13485 certified medical device contract manufacturer providing silicone molding, silicone extrusion, thermoplastic extrusion, tight tolerance silicone sheeting and medical device assembly services. Vesta is recognized for its expertise in material selection and compliance to quality standards for optimal medical product development. RoundTable acquired a majority interest in Vesta in August 2007.

"Vesta's management team, under the direction of its Chief Executive Officer Phillip R. Estes, did a tremendous job of developing state-of-the-art silicone and thermoplastic manufacturing capabilities, helping their customers to provide safe and effective medical devices that improve the lives of patients worldwide," said Joseph F. Damico, Founding Partner and Co-Chairman of RoundTable and Chairman of Vesta. "We believe that Lubrizol will be a strong strategic partner for Vesta going forward, and that its expertise will benefit the company, its customers and employees."

Phillip R. Estes added, "RoundTable has been an ideal partner for Vesta since the initial acquisition in 2007. During our time together, RoundTable supported our efforts to invest in our facilities, strengthen our management team, and expand our manufacturing capacity. They also sourced, identified and executed multiple important acquisitions to complement Vesta's product offerings. As a result, Vesta is well positioned to continue our success into the future."

The sale of Vesta marks the fourth portfolio realization for RoundTable's $500 million equity Fund II that closed in March 2005. William Blair & Company LLC acted as exclusive financial advisor to Vesta, and Vedder Price P.C. acted as exclusive legal advisor to RoundTable in this transaction.

About RoundTable Healthcare Partners

RoundTable Healthcare Partners, Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise. RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs and corporate partners who share a vision and believe in the value creation potential of its partnership model. RoundTable currently manages $1.9 billion in capital, including three equity funds totaling $1.5 billion and two subordinated debt funds totaling $400 million. More information about RoundTable Healthcare Partners can be found at www.roundtablehp.com.


'/>"/>
SOURCE RoundTable Healthcare Partners
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
2. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
3. RoundTable Healthcare Partners Announces Sale of Aspen Surgical Products Holding, Inc. to Hill-Rom Holdings, Inc.
4. RoundTable Healthcare Partners and Argon Medical Devices to Acquire Angiotech Pharmaceuticals Interventional Products Business
5. Contract Manufacturer RMI hosts Central Indiana Jobs Roundtable with U.S. Senator Joe Donnelly
6. RoundTable Healthcare Partners and Argon Medical Devices Complete Acquisition of Angiotech Pharmaceuticals Interventional Products Business
7. Isis Pharmaceuticals to Present at the Leerink Swann Rare Disease Roundtable
8. Patient Recruitment Expert CSS Tapped to Host Master Workshop and Roundtable Discussions at Annual SCRS Site Solutions Summit Conference in October
9. Mast Therapeutics To Present At The Leerink Swann Rare Disease Roundtable On October 2
10. KaloBios to Present at Leerink Swann Rare Disease Roundtable
11. 2013 mHealth Summit Launches First Pharma and Life Sciences Roundtable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... SAN DIEGO and VANCOUVER, British Columbia, March 27, ... SPHS ) (the "Company" or "Sophiris"), a clinical ... treatment of patients with urological diseases, today reported ... and key corporate highlights. Key ... in Clinical Development for Localized Prostate Cancer. During ...
(Date:3/27/2017)... , March 27, 2017 /PRNewswire/ - INVICTUS MD ... IVITF; FRA: 8IS) Invictus MD is pleased to announce ... shares for trading on the TSX Venture Exchange.  ... TSXV follows a year of significant achievements for Invictus-MD. ... successful test crops at AB Laboratories Inc. ("AB Labs"), ...
(Date:3/27/2017)... , March 27, 2017 The ... reach USD 16.0 billion by 2025, according to a ... prevalence of chronic diseases is anticipated to be responsible ... which thereby widens the scope for growth during the ... bariatric population, which is highly susceptible to chronic diseases, ...
Breaking Medicine Technology:
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently ... balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive ...
(Date:3/28/2017)... ... March 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of ... a lot to offer to the discussion of dealing with excess skin oil. “Oily skin ... many home remedies that can help remove the oily shine while keeping the skin fresh ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... with or without a referral. Sleep apnea is often left untreated because patients are ... headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep ...
(Date:3/27/2017)... Philadelphia PA and London UK (PRWEB) , ... ... ... have the speed, agility and ability to gain site attention and engagement over ... DrugDev educational webinar will discuss how partnering with the ...
Breaking Medicine News(10 mins):